Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma
Article in Cancer Cell International (February 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC)
Article in Cell Biochemistry and Function (January 2024)
NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis
Article in Cancer Science (November 2023)